MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

14 hedge funds and large institutions have $987K invested in Stealth BioTherapeutics Corp. ADS in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$49K
2
+$33K
3
+$3.72K
4
HF
HRT Financial
New York
+$3.1K
5
AA
AlphaMark Advisors
Kentucky
+$3K

Top Sellers

1
-$138K
2
-$30.4K
3
-$20.1K
4
PAM
PVG Asset Management
Colorado
-$18.7K
5
BFM
Boothbay Fund Management
New York
-$12.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$651K
2
$91K
3
$66K
4
$49K
5
$35K
6
$33K
7
$26K
8
$20K
9
$8K
10
$4K
11
$3K
12
$1K
13
$238
14
–
15
–